Logo-apb
Adv Pharm Bull. 2023;13(3): 551-562. doi: 10.34172/apb.2023.053
PMID: 37646068        PMCID: PMC10460815

Research Article

CD44 Suppression Improved the Chemosensitivity of HT-29 Colorectal Cancer Cells to 5-Fluorouracil and Inhibited Cell Migration

Souzan Najafi 1,2 ORCID, Zohreh Rahimi 3,4, Behzad Mansoori 2,5,6, Ali Mohammadi 2,5, Fatemeh Mohammadnejad 2, Mohammad Amini 2, Ahad Mokhtazadeh 2, Zahra Asadzadeh 2, William Chi-Shing Cho 7 * ORCID, Behzad Baradaran 2 * ORCID

Cited by CrossRef: 4


1- Shmelev M, Pilnik A, Shved N, Penkova A, Gulaia V, Kumeiko V. IDH1 R132H and TP53 R248Q Mutations Modulate Glioma Cell Migration and Adhesion on Different ECM Components. IJMS. 2024;25(22):12178 [Crossref]
2- Liu J, Zhang Q, Wang J, Wang C, Lan T, Wang T, Wang B. Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer. IJMS. 2023;24(18):14402 [Crossref]
3- Shnaikat S, Shakya A, Bardaweel S. Formulation, development and evaluation of hyaluronic acid-conjugated liposomal nanoparticles loaded with regorafenib and curcumin and their in vitro evaluation on colorectal cancer cell lines. Saudi Pharmaceutical Journal. 2024;32(7):102099 [Crossref]
4- Elias M, Fatima S, Mann T, Karan S, Mikhael M, de Souza P, Gordon C, Scott K, Aldrich-Wright J. Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer. Cancers. 2024;16(14):2544 [Crossref]
5- Elias M, Aputen A, Fatima S, Mann T, Karan S, Mikhael M, de Souza P, Gordon C, Scott K, Aldrich-Wright J. Chemotherapeutic Potential of Chlorambucil-Platinum(IV) Prodrugs against Cisplatin-Resistant Colorectal Cancer Cells. IJMS. 2024;25(15):8252 [Crossref]